Document resource
Less than half of England has access to tirzepatide (Mounjaro) through general practices, despite the NHS roll-out of the weight-loss jab having officially started over two months ago, The BMJ can disclose.
Annotated abstract
bmj · 2025-09-04 · canonical JSON source